A US federal judge has order an injunction to block a proxy fight being waged against ICN Pharmaceuticals by Rafi Khan, and plans to ask federal prosecutors to see if the California stockbroker perjured himself. The ruling will stop Mr Khan's plans to mount a proxy fight by December 15, which is the scheduled date of ICN's annual stockholders' meeting, but Mr Khan's lawyers are now trying to get the date postponed. The judge also nullified consent cards sent by Mr Khan to ICN shareholders.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze